Pharvaris (PHVS) Net Income Growth (3y) (2023 - 2026)
Pharvaris (PHVS) Net Income Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | 9.16% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | - |
| 4 | BeOne Medicines | 472.68 Bn | 467.89 Bn | 1.35 Bn | 38.43% |
| 5 | Vertex Pharmaceuticals | 122.24 Bn | 114.99 Bn | 2.59 Bn | 13.80% |
| 6 | Regeneron Pharmaceuticals | 70.08 Bn | 61.33 Bn | 3.31 Bn | -3.84% |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.75 Bn | 1.41 Bn | 79.26% |
| 9 | Alnylam Pharmaceuticals | 37.59 Bn | 34.58 Bn | 959.66 Mn | 47.10% |
| 10 | Pharvaris | 2.23 Bn | 1.94 Bn | - | -23.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.27% |
| Dec 31, 2025 | -6.83% |
| Sep 30, 2025 | -48.43% |
| Jun 30, 2025 | -88.50% |
| Mar 31, 2025 | -39.03% |
| Dec 31, 2024 | -25.99% |
| Sep 30, 2024 | -62.17% |
| Jun 30, 2024 | -20.30% |
| Mar 31, 2024 | -60.26% |
| Dec 31, 2023 | -43.21% |
| Sep 30, 2023 | -50.28% |
| Jun 30, 2023 | -55.16% |
| Mar 31, 2023 | -88.33% |